66 /100
HIGH RISK
Score updated May 30, 2026

LIMN — Liminatus Pharma, Inc. Dilution Risk Tracker

Track LIMN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LIMN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split 70%
• 50-day avg $0.19 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 1.9 months cash remaining
📉 Score Deterioration 50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (66/100)
🔔 Track LIMN — Get forecast alerts →

💹 Market Data

Market Cap$7.36M
Shares Outstanding44.88M
Float29.07M
Cash$1.91M
Debt$1.44M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 19.9% shares (2025Q4 vs prior)
13 institutional holders · 317.4K shares
#1 VANGUARD GROUP INC 73.4K shares
#2 CITADEL ADVISORS LLC 70.9K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 65.1K shares
+ 10 more holders Sign up free to view →

📉 Short Interest

Short Interest562.4K
Days to Cover1.0
% of Float1.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track LIMN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LIMN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for LIMN
📊 LIMN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LIMN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.